União Química’s Acquisition of Elanco Production Plant

Demarest advised on the deal

União Química finalized the acquisition of bovine growth hormone production plant from Elanco operating as Eli Lilly’s animal health Department.

União Química Farmacêutica Nacional S.A. manufactures and sells pharmaceutical, OTC, and generic medicinal products for hospital and retail markets in Brazil. The company is based in São Paulo.

Demarest advised União Química with a team including Luciana Cossermelli Tornovsky (Picture) Lucas Tavares, Débora Sejtman and Camila Ornellas Smith.

Involved fees earner: Luciana Cossermelli Tornovsky – Demarest; Lucas Tavares Bueno – Demarest; Débora Sejtman – Demarest; Camila Ornellas Smith de Vasconcellos – Demarest;

Law Firms: Demarest;

Clients: União Química Farmacêutica Nacional S.A.;

Author: Ambrogio Visconti.